Objective: To primarily assess the surgical technique to correct incomplete Tessier No. 3 craniofacial cleft.

Methods: From 2009 to 2010, 3 male patients with incomplete Tessier No. 3 craniofacial clefts were treated. Preoperative CT examination of each patient was performed and the bony defect was evaluated. In the operation, van der Meulen rotation and advancement flap of the cheek and regional Z-plasty were used and the medial canthal ligament was repositioned.

Results: One week after the operation, the sutures were removed and the facial incision healed well. The facial scar was not obvious 6 - 10 months after operation. The shape of medial canthal angle was acceptable, and the height of the medial canthal angle and the length of the palpebral fissure of both sides were symmetrical. The clinical results were satisfactory.

Conclusions: For the incomplete Tessier No. 3 craniofacial cleft, surgical treatment is mainly focused on the deformities of inner canthus and nasal alae. Medial canthal ligament reposition is the key procedure for correction of the medial canthal deformity and surgical results are stable and reliable.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1002-0098.2012.03.009DOI Listing

Publication Analysis

Top Keywords

medial canthal
20
incomplete tessier
16
tessier craniofacial
12
craniofacial cleft
8
canthal ligament
8
canthal angle
8
medial
5
canthal
5
[surgical treatment
4
incomplete
4

Similar Publications

Background: Involution or aging is the most common cause of lower eyelid entropion (in-turning of eyelid margin) in the elderly population. Various pathomechanisms have been postulated for its occurrence. Aging leads to laxity of tissues and loss of muscle tone.

View Article and Find Full Text PDF

Background: The medial epicanthal fold is a common ethnic trait in East Asian faces, and there is a significant demand for its correction for cosmetic reasons. Numerous epicanthoplasty techniques have been proposed; however, visible scarring and unnatural canthal shapes have been challenges. This study aimed to introduce a simpler approach for medial epicanthoplasty to address these issues and evaluate its outcomes.

View Article and Find Full Text PDF

Background: With globalization, oculoplastic surgeons must understand the intricate morphological nuances of the periocular region across ethnicities to ensure precise treatment and avoid facial disharmony or dysfunction. Direct comparisons in two-dimensional (2D)-based periocular morphology between studies can be challenging due to the limited number of parameters and complicated variations in equipment, environments, measurement personnel, and methods. Therefore, it is imperative to explore the detailed three-dimensional (3D) periocular morphological disparities between young Caucasian and Chinese populations.

View Article and Find Full Text PDF

Purpose: To highlight a case report of high-grade primary lacrimal sac Burkitt lymphoma in a young adult.

Observation: A 25-year-old gentleman was referred to the oculoplastic center for left eye medial canthal progressive swelling at the level below the medial canthal tendon for two months associated with tearing. He was initially treated for preseptal cellulitis but failed to respond to antibiotics.

View Article and Find Full Text PDF

Atypical lacrimal sac mucoceles.

Orbit

January 2025

Govindram Seksaria Institute of Dacryology, L.V. Prasad Eye Institute, Hyderabad, India.

Purpose: To report the clinical features and operative findings of a series of patients with lacrimal sac mucoceles extending above the anatomic level of the medial canthal tendon (MCT).

Methods: A retrospective chart review of all patients presenting with lacrimal sac mucocele extending above the anatomic level of the MCT over a period of five years from 2019 and 2023. All patients underwent surgical management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!